Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lee Hoonmo — Indaptus Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Lee Hoonmo

Lee Hoonmo

Director at Indaptus Therapeutics, Inc. · on record since Aug 6, 2021
10% owner at Indaptus Therapeutics, Inc. · on record since Aug 6, 2021

Insider trading activity of Lee Hoonmo

Transactions on record: 1; since Aug 6, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 6, 2021

Figures computed from official regulatory filings — methodology.

Companies where Lee Hoonmo has traded

Indaptus Therapeutics, Inc.1 tx · Aug 6, 2021

Track record of Lee Hoonmo

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lee Hoonmo

Co-insiders of Lee Hoonmo

Anderson Glen R.Indaptus Therapeutics, Inc.
Ben-Tzvi AvrahamIndaptus Therapeutics, Inc.
Dai JunyiIndaptus Therapeutics, Inc.
Gilbert Mark JohnIndaptus Therapeutics, Inc.
Hayes William BIndaptus Therapeutics, Inc.
Jabbour Jerome DIndaptus Therapeutics, Inc.
Karah HilaIndaptus Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Lazar David E.Indaptus Therapeutics, Inc.

Linscott Walt AddisonIndaptus Therapeutics, Inc.

Litchev Boyan VesselinovIndaptus Therapeutics, Inc.

Lu QinglaiIndaptus Therapeutics, Inc.

MADDALUNA ANTHONY JIndaptus Therapeutics, Inc.

Martell RobertIndaptus Therapeutics, Inc.

McMurdo Matthew CharlesIndaptus Therapeutics, Inc.

Meckler Jeffrey AIndaptus Therapeutics, Inc.

NATAN DAVIDIndaptus Therapeutics, Inc.

Newman Michael JamesIndaptus Therapeutics, Inc.

O'CALLAGHAN BRIANIndaptus Therapeutics, Inc.

Pomerantz RogerIndaptus Therapeutics, Inc.

Sassi NirIndaptus Therapeutics, Inc.

SINO LION VENTURES LtdIndaptus Therapeutics, Inc.

Waltzman Roger J.Indaptus Therapeutics, Inc.

Yao YunIndaptus Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Indaptus Therapeutics, Inc.	Aug 6, 2021	AwardD	13,750	0.00 USD	$0	SEC